CEO of MariMed Buys 75,000 Shares Immediately After RSU Vesting, Hinting at Undervalued Value
CEO Levine Jon R’s May 7 buy of 75k MariMed shares hints at undervaluation and a bullish outlook for the medical‑cannabis firm.
4 minutes to read
MariMed Inc
MariMed’s Top Execs Offload Half‑Million RSUs: Insider Sell‑Off Sparks Investor Alarm Ahead of Q1 Earnings Flash
Insider selling signals: Shaw Timothy’s April 15 RSU liquidation sparks caution, amid MariMed’s declining stock and 356% social‑media buzz—investors weigh possible downside as Q1 earnings loom.
4 minutes to read
COO Shaw Timothy’s April 2 Trades: A Quiet Confidence Amid MariMed’s Declining Share Price
Shaw Timothy’s recent buy‑sell and RSU moves at MariMed reveal steady executive equity management, giving investors insight into leadership’s confidence amid a volatile share price.
4 minutes to read
MariMed COO Shaw Timothy’s April 2 Share Swap Suggests Routine RSU Conversion, Not a Bold Bet on Stock
COO Shaw Timothy’s recent MariMed share swaps reveal routine RSU conversions, offering investors insight into insider confidence amid a bearish market.
3 minutes to read